Prognostic values of inflammation and immune-based scores in patients with hepatocellular carcinoma who undergo transarterial chemoembolization

被引：0
|
作者：
Cho, Eun Ju [1 ]
Yu, Su Jong [1 ]
Cho, Hyeki [1 ]
Kang, Seong Hee [1 ]
Cho, Young Youn [1 ]
Lee, Jeong-Hoon [1 ]
Kim, Yoon Jun [1 ]
Yoon, Jung-Hwan [1 ]
机构：
[1] Seoul Natl Univ Hosp, Internal Med, Seoul, South Korea
来源：
HEPATOLOGY | 2016年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1321
引用
收藏
页码：661A / 661A
页数：1
相关论文
共 50 条
  • [21] Comparison of the prognostic value of inflammation-based prognostic scores in patients with hepatocellular carcinoma
    A Kinoshita
    H Onoda
    N Imai
    A Iwaku
    M Oishi
    N Fushiya
    K Koike
    H Nishino
    H Tajiri
    British Journal of Cancer, 2012, 107 : 988 - 993
  • [22] Role of Radiofrequency Ablation in Patients with Hepatocellular Carcinoma Who Undergo Prior Transarterial Chemoembolization: Long-Term Outcomes and Predictive Factors
    Sohn, Won
    Choi, Moon Seok
    Cho, Ju Yeon
    Gwak, Geum-Youn
    Paik, Yong-Han
    Lee, Joon Hyeok
    Koh, Kwang Cheol
    Paik, Seung Woon
    Yoo, Byung Chul
    GUT AND LIVER, 2014, 8 (05) : 543 - 551
  • [23] Prognostic factors in hepatocellular carcinoma patients undergoing transarterial chemoembolization and radioembolization: a retrospective study
    Jeliazkova, Petia
    Umgelter, Andreas
    Braren, Rickmer
    Kaissis, Georgios
    Mustafa, Mona
    Einwaechter, Henrik
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2020, 32 (08) : 1036 - 1041
  • [24] PROGNOSTIC INDICATION OF TRANSARTERIAL CHEMOEMBOLIZATION AND MULTIKINASE INHIBITORS IN PATIENTS WITH INTERMEDIATE STAGE HEPATOCELLULAR CARCINOMA
    Shimose, Shigeo
    Kawaguchi, Takumi
    Iwamoto, Hideki
    Takashi, Niizeki
    Shirono, Tomotake
    Tanaka, Masatoshi
    Koga, Hironori
    Torimura, Takuji
    HEPATOLOGY, 2019, 70 : 214A - 214A
  • [25] Prognostic value of preoperative serum ferritin in hepatocellular carcinoma patients undergoing transarterial chemoembolization
    Fan, Mi
    Niu, Tingting
    Lin, Binwei
    Gao, Feng
    Tan, Bangxian
    Du, Xiaobo
    MOLECULAR AND CLINICAL ONCOLOGY, 2024, 20 (03)
  • [26] MicroRNAs as effective prognostic biomarkers in transarterial chemoembolization procedure for hepatocellular carcinoma patients - Correspondence
    Sekaran, Saravanan
    Vimalraj, Selvaraj
    Ganapathy, Dhanraj
    INTERNATIONAL JOURNAL OF SURGERY, 2022, 107
  • [27] Risk Prognostic Factors With Transarterial Chemoembolization for Patients of Medium-stage Hepatocellular Carcinoma
    Yen, Chieh-Ling
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2015, 13 (07) : E119 - E120
  • [28] A Prognostic Score for Patients with Intermediate-Stage Hepatocellular Carcinoma Treated with Transarterial Chemoembolization
    Ogasawara, Sadahisa
    Chiba, Tetsuhiro
    Ooka, Yoshihiko
    Kanogawa, Naoya
    Motoyama, Tenyu
    Suzuki, Eiichiro
    Tawada, Akinobu
    Azemoto, Ryosaku
    Shinozaki, Masami
    Yoshikawa, Masaharu
    Yokosuka, Osamu
    PLOS ONE, 2015, 10 (04):
  • [29] Prognostic factors for acute kidney injury following transarterial chemoembolization in patients with hepatocellular carcinoma
    Zhou, Chunze
    Wang, Ruifeng
    Ding, Yikun
    Du, Linan
    Hou, Changlong
    Lu, Dong
    Hao, Li
    Lv, Weifu
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2014, 7 (05): : 2579 - 2586
  • [30] Prognostic values of immune scores and immune microenvironment-related genes for hepatocellular carcinoma
    Ge, Peng-lei
    Li, Shi-fang
    Wang, Wei-wei
    Li, Chun-bo
    Fu, Yu-bin
    Feng, Zheng-kai
    Li, Lin
    Zhang, Gong
    Gao, Zhi-qiang
    Dang, Xiao-wei
    Wu, Yang
    AGING-US, 2020, 12 (06): : 5479 - 5499
12345